HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Han Xiao Selected Research

Chimeric Antigen Receptors

10/2022CD20-specific chimeric antigen receptor-expressing T cells as salvage therapy in rituximab-refractory/relapsed B-cell non-Hodgkin lymphoma.
1/2022CD19 or CD20 CAR T Cell Therapy Demonstrates Durable Antitumor Efficacy in Patients with Central Nervous System Lymphoma.
1/2016Design of Switchable Chimeric Antigen Receptor T Cells Targeting Breast Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Han Xiao Research Topics

Disease

86Neoplasms (Cancer)
04/2024 - 06/2006
27Inflammation (Inflammations)
02/2024 - 08/2013
20Fibrosis (Cirrhosis)
11/2023 - 03/2008
19Neoplasm Metastasis (Metastasis)
04/2024 - 06/2006
19Hepatocellular Carcinoma (Hepatoma)
04/2024 - 01/2017
16Infections
06/2023 - 01/2009
14Breast Neoplasms (Breast Cancer)
01/2024 - 12/2007
13COVID-19
02/2024 - 01/2020
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 01/2021
10Cardiomegaly (Heart Hypertrophy)
12/2023 - 12/2007
8Heart Failure
01/2024 - 01/2012
7Cerebral Hemorrhage
05/2023 - 01/2020
7Ischemia
06/2022 - 12/2012
6Lung Neoplasms (Lung Cancer)
03/2023 - 05/2009
6Hypoxia (Hypoxemia)
09/2021 - 12/2012
5Hypertension (High Blood Pressure)
01/2024 - 04/2011
5Atherosclerosis
11/2023 - 04/2011
5Adenocarcinoma of Lung
10/2023 - 01/2019
5Colorectal Neoplasms (Colorectal Cancer)
03/2023 - 06/2006
5Brain Ischemia (Cerebral Ischemia)
01/2022 - 01/2012
4Ischemic Stroke
02/2024 - 01/2021
4Prostatic Neoplasms (Prostate Cancer)
01/2024 - 01/2018
4Disease Progression
11/2023 - 06/2014
4Fatigue
11/2023 - 11/2012
4Multiple Myeloma
01/2023 - 01/2019
4Neuroinflammatory Diseases
11/2022 - 01/2021
4Cardiovascular Diseases (Cardiovascular Disease)
10/2022 - 01/2009
4Triple Negative Breast Neoplasms
01/2022 - 01/2021
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2021 - 12/2012
4Hypertrophy
03/2020 - 09/2010
4Squamous Cell Carcinoma of Head and Neck
01/2020 - 11/2012
3Cholangiocarcinoma
04/2024 - 06/2020
3Thrombosis (Thrombus)
04/2024 - 12/2013
3Carcinogenesis
03/2024 - 01/2021
3Hemorrhage
02/2024 - 04/2019
3Postpartum Depression (Post-Natal Depression)
01/2024 - 11/2021
3Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 04/2023
3Renal Cell Carcinoma (Grawitz Tumor)
11/2023 - 12/2020
3Sleep Initiation and Maintenance Disorders (Insomnia)
11/2023 - 01/2022
3Melanoma (Melanoma, Malignant)
01/2023 - 06/2006
3Neurodegenerative Diseases (Neurodegenerative Disease)
11/2022 - 04/2011
3Brain Injuries (Brain Injury)
11/2022 - 01/2017
3Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 01/2016
3Brain Edema (Cerebral Edema)
01/2022 - 01/2021
3Body Weight (Weight, Body)
08/2021 - 01/2018
3Myocardial Infarction
02/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

31Proteins (Proteins, Gene)FDA Link
03/2024 - 11/2006
18Biomarkers (Surrogate Marker)IBA
03/2024 - 05/2009
13Adrenergic Receptors (Adrenergic Receptor)IBA
07/2023 - 01/2012
12CytokinesIBA
06/2023 - 06/2006
11EnzymesIBA
01/2024 - 06/2014
10Messenger RNA (mRNA)IBA
04/2024 - 11/2006
10InflammasomesIBA
05/2023 - 08/2013
9DNA (Deoxyribonucleic Acid)IBA
04/2024 - 06/2006
9AntibodiesIBA
11/2023 - 01/2017
8Estrogens (Estrogen)FDA Link
02/2024 - 01/2020
7Isoproterenol (Isoprenaline)FDA LinkGeneric
12/2023 - 01/2014
7Metformin (Glucophage)FDA LinkGeneric
01/2023 - 08/2010
7Peptides (Polypeptides)IBA
01/2023 - 11/2006
7Therapeutic UsesIBA
01/2023 - 11/2006
7Neuroprotective AgentsIBA
11/2022 - 12/2012
6AntigensIBA
01/2024 - 03/2007
6AMP-Activated Protein KinasesIBA
05/2023 - 09/2010
6Glucose (Dextrose)FDA LinkGeneric
01/2023 - 12/2012
5Oxygen (Dioxygen)IBA
04/2024 - 12/2012
5Estrogen ReceptorsIBA
02/2024 - 01/2017
5VaccinesIBA
02/2024 - 06/2006
5ChemokinesIBA
11/2023 - 01/2008
5LipidsIBA
11/2023 - 01/2020
5RNA (Ribonucleic Acid)IBA
07/2023 - 01/2019
5MicroRNAs (MicroRNA)IBA
01/2021 - 03/2012
5Interleukin-6 (Interleukin 6)IBA
03/2020 - 12/2007
4Sialic Acid Binding Immunoglobulin-like LectinsIBA
01/2024 - 01/2016
4CatecholaminesIBA
11/2023 - 01/2012
4Adrenergic Agents (Adrenergic Drugs)IBA
01/2023 - 11/2016
4Interleukin-18 (Interleukin 18)IBA
01/2023 - 01/2018
3Cisplatin (Platino)FDA LinkGeneric
02/2024 - 05/2013
3Tuberculin (PPD)IBA
01/2024 - 11/2021
3C-Reactive ProteinIBA
01/2024 - 01/2020
3Eosine Yellowish-(YS) (Eosin)IBA
12/2023 - 11/2021
3Immune Checkpoint InhibitorsIBA
11/2023 - 01/2020
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2023 - 03/2013
3InterferonsIBA
09/2023 - 12/2013
3Transfer RNA (tRNA)IBA
06/2023 - 11/2021
3ImmunosorbentsIBA
05/2023 - 05/2017
3Transcription Factors (Transcription Factor)IBA
05/2023 - 02/2021
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2023 - 01/2018
3Chimeric Antigen ReceptorsIBA
10/2022 - 01/2016
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
06/2022 - 01/2021
3Trastuzumab (Herceptin)FDA Link
03/2022 - 01/2016
3NLR ProteinsIBA
09/2021 - 01/2020

Therapy/Procedure

49Therapeutics
04/2024 - 01/2003
17Immunotherapy
01/2024 - 06/2006
13Drug Therapy (Chemotherapy)
04/2024 - 06/2006
11Radiotherapy
04/2024 - 01/2016
4Radiofrequency Ablation
01/2024 - 11/2018
3Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2024 - 01/2017
3Subcutaneous Injections
10/2022 - 01/2016
3Hepatectomy
01/2022 - 11/2018
3Aftercare (After-Treatment)
01/2022 - 11/2006